logo

iStock Rating

D
Details...
Enter Symbol click to research

Pharmacyclics, Inc. (NASDAQ: PCYC)

Sector: Medical

Current Price : $82.35

52 Week Low
$26.2452 Week High
$94.20
 

PHARMACYCL(NSDQ:PCYC)
Pharmacyclics Inc. is a pharmaceutical company developing products to improve upon therapeutic approaches to cancer, atherosclerosis and retinal disease. The company''s products are ring-shaped small molecules called texaphyrins. These patented agents are derived from Pharmacyclics'' versatile technology platform for designing and synthesizing energy-potentiating drugs. The texaphyrins localize in cancer cells, atherosclerotic plaque and neovasculature, where they can be activated by forms of energy, including X-rays and light to reduce diseased tissue.
# Employees: 150
Address: 995 E ARQUES AVE,SUNNYVALE,CA,USA
Phone: 4087740330
Fax: 408-774-0340
Website: http://www.pharmacyclics.com
Email:
Sector: Medical
Industry: MED-DRUGS
Executive Officers
Robert W. Duggan (Chmn.of the Board & C.E.O.)
Rainer M. Erdtmann (V.P.;Fin.and Admin.& Sec.)
Robert F. Booth (Director)
Eric H. Halvorson (Director)
Roy C. Hardiman (Director,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 12/31/2012
Next Earnings Date(Expected): 5/9/2013
Mean EPS (Next Qtr): ($0.04)
Mean EPS (Year): ($0.43)
Mean Estimate(Long Term): ($0.01)
P/E Ratio(Based on EPS estimate): -0.010
Number of Estimates: 8
Shares Performance
Period pcyc Compare to S&P
YTD 34.16 % 23.03 %
4 Weeks -0.74 % -0.64 %
12 Weeks 8.42 % 4.77 %
Shares Information
Analyst Coverage: Y
Avg Volume: 674899
Shares Outstanding: 72M
Market Cap: $5.61B
52 Week High: $94.20
52 Week Low: $26.24
P/E Ratio: 67.410
PEG Ratio: -0.010
Split: On 1/1/1990 pcyc split by factor of 0.100
Earnings Performance
EPS Growth in Last Quarter: -45.10 %
EPS Growth in Last Year: -28.21 %
Sales Growth in Last Quarter: -43.56 %
Sales Growth in Last Quarter: -25.60 %
Financials
Qtr Book Value: $20.54
Cash Flow/Share: ($0.01)
Change in Payout Ratio: -0.010
Price/Sales: -0.010
Home | Login |Research | Earnings | Scans | Charts | Submit Article | Join Blog Network | Advertise | Subscribe to RSS

Terms of Use | Privacy Policy | Copyright 2012 all rights reserved
Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.